Croda signs supply contract with Pfizer for COVID-19 vaccine excipients

Croda entered into a five-year agreement with Pfizer to supply novel excipients for a COVID-19 vaccine candidate. The initial supply contract covers four component excipients for the first three years.

“Croda, the speciality chemical company has entered into an agreement with Pfizer to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate”ddw-online.com

• 1 source
• ddw-online.comCroda contract for Pfizer COVID-19 vaccine - Drug Discovery World (DDW)Lu RahmanNov 11, 2020

Summarized from public sources; check the original articles before acting on it.